Overview

Evaluate Recovery of Testosterone for Patients Using Eligard

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if testosterone will recover to 90% by year 1 after using Eligard.
Phase:
Phase 4
Details
Lead Sponsor:
Chesapeake Urology Research Associates
Collaborator:
Sanofi-Synthelabo
Treatments:
Leuprolide
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate